人乳腺癌组织中的雌激素受体及对内分泌治疗的反应
Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.
作者信息
Engelsman E, Persijn J P, Korsten C B, Cleton F J
出版信息
Br Med J. 1973 Jun 30;2(5869):750-2. doi: 10.1136/bmj.2.5869.750.
Abstract
Oestrogen receptor determinations were done in metastatic breast cancer tissue of patients with advanced breast cancer. In 37 patients with progressive disease evaluation of the response to endocrine treatment was possible, following the criteria of the E.O.R.T.C. Co-operative Breast Cancer Group. In 20 patients with receptor-negative tumours two objective remissions were noted; in 17 patients with receptor-positive tumours 14 objective remissions were seen. There seems to be a striking correlation between the presence or absence of oestrogen receptor in tumour tissue and the clinical response to hormonal therapy.
摘要
对晚期乳腺癌患者的转移性乳腺癌组织进行了雌激素受体测定。按照欧洲癌症研究与治疗组织（E.O.R.T.C.）合作乳腺癌组的标准，对37例病情进展的患者进行了内分泌治疗反应评估。在20例受体阴性肿瘤患者中，观察到2例客观缓解；在17例受体阳性肿瘤患者中，观察到14例客观缓解。肿瘤组织中雌激素受体的有无与激素治疗的临床反应之间似乎存在显著相关性。
相似文献
1
Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.人乳腺癌组织中的雌激素受体及对内分泌治疗的反应
Br Med J. 1973 Jun 30;2(5869):750-2. doi: 10.1136/bmj.2.5869.750.
2
Human breast cancer and estrogen receptor.人类乳腺癌与雌激素受体
Arch Chir Neerl. 1973;25(4):393-7.
3
The prediction of hormonal dependency of mammary cancer.乳腺癌激素依赖性的预测。
Ann Surg. 1975 Sep;182(3):342-52. doi: 10.1097/00000658-197509000-00017.
4
Estrogen receptors in human breast cancer tissue.
Am J Obstet Gynecol. 1972 Jun 1;113(3):377-82. doi: 10.1016/0002-9378(72)90688-6.
5
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.萘福昔定与炔雌醇治疗晚期乳腺癌的对比试验：一项欧洲癌症研究与治疗组织（E.O.R.T.C.）的研究
Br Med J. 1975 Jun 28;2(5973):711-3. doi: 10.1136/bmj.2.5973.711.
6
Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancer.诺氟沙星（一种雌激素拮抗剂）用于晚期乳腺癌的临床试验。
Eur J Cancer (1965). 1972 Aug;8(4):387-9. doi: 10.1016/0014-2964(72)90121-1.
7
Hormone therapy of breast cancer with special reference to masteril therapy.乳腺癌的激素治疗，特别提及马斯特里尔疗法。
S Afr Med J. 1972 Aug 26;46(34):1195-9.
8
Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?三联激素受体检测：治疗晚期乳腺癌更准确的预测工具？
Br J Cancer. 1979 Dec;40(6):862-5. doi: 10.1038/bjc.1979.277.
9
Hormonal therapy of cancer of the female breast.女性乳腺癌的激素治疗
Appl Ther. 1969 Feb;11(2):84-7.
10
Oestrogen receptors in relation to human breast cancer.与人类乳腺癌相关的雌激素受体
Ric Clin Lab. 1977 Jan-Mar;7(1):47-74. doi: 10.1007/BF02886602.
引用本文的文献
1
Letter: Breast cancer regression under oestrogen therapy.信件：雌激素治疗下的乳腺癌消退
Br Med J. 1974 Mar 2;1(5904):390. doi: 10.1136/bmj.1.5904.390.
2
Letter: Breast cancer regression under oestrogen therapy.信件：雌激素治疗下的乳腺癌消退
Br Med J. 1973 Nov 17;4(5889):419-20. doi: 10.1136/bmj.4.5889.419-a.
3
Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.抗雌激素药物治疗乳腺癌：52例晚期病例中萘福昔定的价值。
Br Med J. 1974 Apr 6;2(5909):7-10. doi: 10.1136/bmj.2.5909.7.
4
Endogenous steroid concentrations in human breast tumours determined by high-resolution mass fragmentography.通过高分辨率质量碎片分析法测定人乳腺肿瘤中的内源性类固醇浓度。
Biochem J. 1974 May;139(2):473-5. doi: 10.1042/bj1390473.
5
[Histological diagnosis, DNA-content and chromatin pattern of breast cancer cases with positive and negative 17-beta-oestradiol receptor binding (author's transl)].[17-β-雌二醇受体结合阳性和阴性乳腺癌病例的组织学诊断、DNA含量及染色质模式（作者译）]
Arch Gynakol. 1976 Dec 10;221(4):323-38. doi: 10.1007/BF00667026.
6
Estrogen receptors in breast cancer.乳腺癌中的雌激素受体
World J Surg. 1977 May;1(3):341-2. doi: 10.1007/BF01556853.
7
High affinity oestradiol receptors and the activity of glucose-6-phosphate dehydrogenase and lactose synthetase in mammary carcinomata of postmenopausal women.绝经后女性乳腺癌中高亲和力雌二醇受体与葡萄糖-6-磷酸脱氢酶及乳糖合成酶的活性
Br J Cancer. 1975 Apr;31(4):424-8. doi: 10.1038/bjc.1975.81.
8
Oestrogen receptors in breast cancer: a changing concept.乳腺癌中的雌激素受体：一个不断变化的概念。
Br Med J. 1975 Jan 25;1(5951):185-9. doi: 10.1136/bmj.1.5951.185.
本文引用的文献
1
THE UPTAKE OF (6,7-3-H)OESTRADIOL BY DIMETHYLBENZANTHRACENE-INDUCED RAT MAMMARY TUMOURS.二甲基苯并蒽诱导的大鼠乳腺肿瘤对（6,7-³H）雌二醇的摄取
J Endocrinol. 1965 Apr;32:83-90. doi: 10.1677/joe.0.0320083.
2
Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy.氚标记己烷雌酚在晚期乳腺癌中的研究。己烷雌酚的组织蓄积与双侧肾上腺切除术和卵巢切除术反应的比较。
Lancet. 1961 Oct 7;2(7206):796-8. doi: 10.1016/s0140-6736(61)91088-1.
3
The intranuclear localization of [6,7-3H]-oestradiol-17-beta in dimethylbenzanthracene-induced rat mammary adenocarcinoma and other tissues.[6,7-3H]-雌二醇-17-β在二甲基苯并蒽诱导的大鼠乳腺腺癌及其他组织中的核内定位
J Endocrinol. 1966 Oct;36(2):139-50. doi: 10.1677/joe.0.0360139.
4
Estrogen receptors in human breast cancer tissue.
Am J Obstet Gynecol. 1972 Jun 1;113(3):377-82. doi: 10.1016/0002-9378(72)90688-6.
5
Prognostic significance of oestrogen uptake by human breast-cancer tissue.人乳腺癌组织雌激素摄取的预后意义
Lancet. 1973 Jan 27;1(7796):163-5. doi: 10.1016/s0140-6736(73)90001-9.
Zotero 插件